Does RUXOLITINIB Cause Thrombocytosis? 179 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 179 reports of Thrombocytosis have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.3% of all adverse event reports for RUXOLITINIB.
179
Reports of Thrombocytosis with RUXOLITINIB
0.3%
of all RUXOLITINIB reports
24
Deaths
63
Hospitalizations
How Dangerous Is Thrombocytosis From RUXOLITINIB?
Of the 179 reports, 24 (13.4%) resulted in death, 63 (35.2%) required hospitalization, and 3 (1.7%) were considered life-threatening.
Is Thrombocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 179 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Thrombocytosis?
ROMIPLOSTIM (234)
METHOTREXATE (135)
CLOZAPINE (123)
ADALIMUMAB (94)
GEMCITABINE (71)
PREDNISONE (71)
GEMCITABINE\GEMCITABINE (67)
PACLITAXEL (64)
CARBOPLATIN (63)
ELTROMBOPAG (58)
Which RUXOLITINIB Alternatives Have Lower Thrombocytosis Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE